AIM: £4.81 (+0.15) | Nasdaq: $34.13 (+0.85)
News Archive

Our latest announcements or presentations are available by selecting the desired News Type.

Announcements can be further filtered by topic using the News Topic check boxes.

 

The full text of all announcements are available for download in the form of PDF files.  For convenience, the text of some announcements have been partially or fully rendered as web pages.  Should any inconsistencies exist, the PDF version shall prevail.

News Type
Presentations
RNS Announcements
News Topics
Commercial Platform
Group
Innovation Platform
Regulatory Notice
12345
6
found Documents: 263
Innovation Platform, RNS Announcements | 22 Nov 2007

Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
a071122
Innovation Platform, RNS Announcements | 20 Aug 2007

Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
a070820
Group, RNS Announcements | 9 Aug 2007

Interim Results for the Six Months Ended 30 June 2007
a070809
Innovation Platform, RNS Announcements | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
a070702
Innovation Platform, RNS Announcements | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
a070618
Innovation Platform, RNS Announcements | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
a070523
Group, RNS Announcements | 21 Mar 2007

Preliminary Results for the year ended 31 December 2006
a070321
Commercial Platform, RNS Announcements | 17 Jan 2007

Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
a070117
Innovation Platform, RNS Announcements | 20 Nov 2006

Chi-Med and Merck KGaA Start Collaboration to Discover Novel Small Molecule Anti-Cancer Drugs
a061120
Innovation Platform, RNS Announcements | 6 Nov 2006

Development Agreement with Procter & Gamble for the Discovery and Development of New Active Ingredients for Beauty Products
a061106
Group, RNS Announcements | 9 Aug 2006

Financial Results for the Six Months Ended 30 June 2006
p060809
Group, RNS Announcements | 17 Jul 2006

Trading Update
a060717
Innovation Platform, RNS Announcements | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
a060704
12345
6